How big is the Oral Anti-Diabetic Drugs Market?

The Oral Anti-Diabetic Drugs Market size is expected to reach USD 46.82 billion in 2024 and grow at a CAGR of 4.17% to reach USD 57.44 billion by 2029. Read More

What is the current Oral Anti-Diabetic Drugs Market size?

In 2024, the Oral Anti-Diabetic Drugs Market size is expected to reach USD 46.82 billion. Read More

Who are the key players in Oral Anti-Diabetic Drugs Market?

Eli Lilly and Company, Astellas Pharma Inc., Sanofi S.A., Janssen Pharmaceuticals and AstraZeneca are the major companies operating in the Oral Anti-Diabetic Drugs Market. Read More

Which is the fastest growing region in Oral Anti-Diabetic Drugs Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Oral Anti-Diabetic Drugs Market?

In 2024, the Asia-Pacific accounts for the largest market share in Oral Anti-Diabetic Drugs Market. Read More

What years does this Oral Anti-Diabetic Drugs Market cover, and what was the market size in 2023?

In 2023, the Oral Anti-Diabetic Drugs Market size was estimated at USD 44.95 billion. The report covers the Oral Anti-Diabetic Drugs Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Oral Anti-Diabetic Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Oral Anti Diabetic Drugs Market - Size, Share & Industry Analysis

Oral Anti Diabetic Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Global Oral Anti Diabetic Drugs Market is Segmented into Drugs (Biguanides (Metformin), Alpha-glucosidase inhibitors, Dopamine-D2 receptor agonists (Bromocriptin (Cycloset)), Sodium-glucose Cotransport-2 (SGLT-2) inhibitor (Invokana (Canagliflozin), Jardiance (Empagliflozin), Farxiga/Forxiga (Dapagliflozin), and Suglat (Ipragliflozin)), Dipeptidyl Peptidase-4 (DPP-4) Inhibitors (Januvia (Sitagliptin), Onglyza (Saxagliptin), Tradjenta (Linagliptin), Vipidia/Nesina (Alogliptin), and Galvus (Vildagliptin)), Sulfonylureas, and Meglitinides), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America). The market provides the value (in USD million) and volume (in units million) for the above segments.

Oral Anti Diabetic Drugs Industry Overview

The oral anti-diabetes drug market is moderately fragmented, with major manufacturers like Eli Lilly, AstraZeneca, Sanofi, Janssen Pharmaceuticals, etc., having a global market presence. In contrast, the remaining manufacturers are confined to the other local or regional markets.